A 25-year follow-up of patients admitted to methadone treatment for the first time: Mortality and gender differences

Addictive Behaviors

Volumn 36, Issue 12, 2011, Pages 1184-1190

  Jimenez Treviño, Luis ^a   Saiz, Pilar A ^a   García Portilla, M Paz ^a   Díaz Mesa, Eva M ^b   Sánchez Lasheras, Fernando ^c   Burón, Patricia ^a   Casares, M José ^a   Marina, Pedro ^a   Gutiérrez, Eduardo ^d   Bobes, Julio ^a  

^a UNIVERSITY OF OVIEDO   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^c Research Department   (Spain)

^d Unidad de Coordinación para el Plan sobre Drogas para   (Spain)

Author keywords

Gender; Heroin addiction; Methadone Maintenance Therapy; Mortality

Indexed keywords

DIAMORPHINE; METHADONE;

ADULT; ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; DRUG DEPENDENCE TREATMENT; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS C; HEROIN DEPENDENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; MORTALITY; PROSPECTIVE STUDY; SEX DIFFERENCE; SURVIVOR; TREATMENT OUTCOME;

ADULT; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B; HEPATITIS C; HEROIN DEPENDENCE; HIV INFECTIONS; HUMANS; MALE; METHADONE; MIDDLE AGED; PROSPECTIVE STUDIES; SEX FACTORS; SPAIN; TREATMENT OUTCOME;

EID: 80053176643     PISSN: 03064603     EISSN: 18736327     Source Type: Journal    
DOI: 10.1016/j.addbeh.2011.07.019     Document Type: Article

References (50)

1. Appel P.W., Joseph H., Richman B. Causes and rates of death among methadone maintenance patients before and after the onset of the HIV/AIDS epidemic. The Mount Sinai Journal of Medicine 2000, 67:444-451.
2. Bauer S.M., Loipl R., Jagsch R., Gruber D., Risser D., Thau K., et al. Mortality in opioid-maintained patients after release from an addiction clinic. European Addiction Research 2008, 14:82-91.
3. Becker J.B., Hu M. Sex differences in drug abuse. Frontiers in Neuroendocrinology 2008, 29:36-47.
4. Brugal M.T., Domingo-Salvany A., Puig R., Barrio G., Garcia de Olalla P., De la Fuente L. Evaluating the impact of methadone maintenance programmes on the mortality due to overdose and AIDS in a cohort of heroin users in Spain. Addiction 2005, 100:981-989.
5. Caplehorn J.R.M., Dalton S.Y.N., Cluff M.C., Petrenas A.M. Retention in methadone maintenance and heroin addicts' risk of death. Addiction 1994, 89:203-207.
6. Caplehorn J.R.M., Dalton S.Y.N., Haldar F., Petrenas A.M., Nisbet J.G. Methadone maintenance and addicts' risk of fatal heroin overdose. Substance Use & Misuse 1996, 31(Suppl. 2):177-196.
7. Coffin P.O., Galea S., Athern J., Leon A.C., Vlahov D., Tardiff K. Opiates, cocaine and alcohol combinations in accidental drug overdose deaths in New York City, 1990-98. Addiction 2003, 98:739-747.
8. Darke S., Ross J., Mills K.L., Williamson A., Havard A., Teesson M. Patterns of sustained heroin abstinence amongst long-term, dependent heroin users: 36months findings from the Australian Treatment Outcome Study (ATOS). Addictive Behaviors 2007, 32(9):1897-1906.
9. Davstad I., Stenbacka M., Leifman A., Romelsjö A. An 18-year follow-up of patients admitted to methadone treatment for the first time. Journal of Addictive Diseases 2009, 28(1):39-52.
10. Finkelstein D.M., Muzikansky A., Schoenfeld D.A. Comparing survival of a sample to that of a standard population. Journal of the National Cancer Institute 2003, 95:1434-1439.
11. Fridell M., Hesse M. Psychiatric severity and mortality in substance abusers: A 15-year follow-up of drug users. Addictive Behaviors 2006, 31:559-565.
12. Frischer M., Goldberg D., Rahman M., Berney L. Mortality and survival among a cohort of drug injectors in Glasgow, 1982-1994. Addiction 1997, 92(4):419-427.
13. Gearing F.R., Schweitzer M.D. An epidemiologic evaluation of long-term methadone maintenance treatment for heroin addiction. American Journal of Epidemiology 1974, 100:101-112.
14. Goldstein A., Herrera J. Heroin addicts and methadone treatment in Albuquerque: A 22-year follow-up. Drug and Alcohol Dependence 1995, 40(2):139-150.
15. Guy W. ECDEU assessment manual for psychopharmacology 1976, U.S. Department of Health, Education, and Welfare, Rockville, MD, USA.
16. Haastrup S., Jepsen P.W. Eleven year follow-up of 300 young opioid addicts. Acta Psychiatrica Scandinavica 1988, 77:22-26.
17. Hall W., Lynskey M., Degenhardt L. Trends in opiate-related deaths in the United Kingdom andAustralia, 1985-1995. Drug and Alcohol Dependence 2000, 57:247-254.
18. Heinemann A., Iwersen-Bergmann S., Stein S., Schmoldt A., Püschel K. Methadone-related fatalities in Hamburg 1990-1999: Implications for quality standards in maintenance treatment?. Forensic Science International 2000, 113(1-3):449-455.
19. Hickman M., Carnwath Z., Madden P., Farell M., Rooney C., Ashcroft R., et al. Drug-related mortality and fatal overdose risk: Pilot cohort study of heroin users recruited from specialist drug treatment sites in London. Journal of Urban Health 2003, 80:274-287.
20. Hser Y.I., Hoffman V., Grella C.E., Anglin M.D. A 33-year follow-up of narcotics addicts. Archives of General Psychiatry 2001, 58(5):503-508.
21. Hubbard R.L., Craddock S.G., Anderson J. Overview of 5-year follow-up outcomes in the drug abuse treatment outcome studies (DATOS). Journal of Substance Abuse Treatment 2003, 25(3):125-134.
22. Instituto Nacional de Estadística Mujeres y Hombres en España, 2009 (Women and Men in Spain, 2009) 2010, INE, Madrid, Spain.
23. Jimenez L., Saiz P.A., Gutierrez E., Bascaran M.T., Carreño E., González-Quiros M., et al. Valoración transversal tras quince años en una muestra de adictos a opiáceos en Asturias. Adicciones 2000, 12(4):507-513.
24. Kleber H.D. Methadone maintenance 4 decades later: Thousands of lives saved but still controversial. JAMA 2008, 300(19):2303-2305.
25. Lynch W.J., Roth M.E., Carroll M.E. Biological basis of sex differences in drug abuse: Preclinical and clinical studies. Psychopharmacology (Berl) 2002, 164:121-137.
26. Marrero C.A., Robles R.R., Colon H.M., Reyes J.C., Matos T.D., Sahai H., et al. Factors associated with drug treatment dropout among injecting drug users in Puerto Rico. Addictive Behaviors 2005, 30:397-402.
27. Mattick R.P., Degenhardt L. Methadone-related and heroin-related deaths among opiate users: Methadone helps save lives. Addiction 2003, 98:387-388.
28. Muga R., Roca J., Egea J.M., Tor J., Sirera G., Rey-Joly C., et al. Mortality of HIV-positive and HIV-negative heroin abusers as a function of duration of injecting drug use. Journal of Acquired Immune Deficiency Syndromes 2000, 23:332-338.
29. National Institutes of Health Effective medical treatment of opiate addiction. NIH Consensus Statement 1997, 15(6):1-38.
30. Nehkant H., Rathod W., Addenbrooke M., Rosenbach A.F. Heroin dependence in an English town: 33-year follow-up. The British Journal of Psychiatry 2005, 18(7):421-425.
31. Ochoa E., Madoz-Gúrpide A., Salvador E. Gender differences in the treatment of the opiate dependence with naltrexone. Actas Españolas de Psiquiatría 2008, 36(4):197-204.
32. Oppenheimer E., Tobutt C., Taylor C., Andrew T. Death and survival in a cohort of heroin addicts from London clinics: A 22-year follow-up study. Addiction 1994, 89:1299-1308.
33. Ortí R.M., Domingo-Salvany A., Munoz A., Mactarlane D., Suelves J.M., Antò J.M. Mortality trends in a cohort of opiate addicts, Catalonia, Spain. International Journal of Epidemiology 1996, 25:545-553.
34. Perucci C.A., Davoli M., Rapiti E., Forastiere F., Abeni D.D. Mortality of intravenous drug users in Rome: A cohort study. American Journal of Public Health 1991, 81:1307-1310.
35. Quaglio G., Talamini G., Lechi A., Venturini L., Lugoboni F., Gruppo Intersert Di Collaborazione Scientifica (GICS), et al. Study of 2708 heroin-related deaths in north-eastern Italy 1985-98 to establish the main causes of death. Addiction 2001, 96:1127-1137.
36. R Development Core Team R: A language and environment for statistical computing 2009, R Foundation for Statistical Computing, Vienna.
37. Ravndal E., Vaglum P. Psychopathology, treatment completion and 5 years outcome. A prospective study of drug abusers. Journal of Substance Abuse Treatment 1998, 15(2):135-142.
38. Rehm J., Frick U., Hartwig C., Gutzwiller F., Gschwend P., Uchtenhagen A. Mortality in heroin-assisted treatment in Switzerland 1994-2000. Drug and Alcohol Dependence 2005, 79:137-143.
39. Risser D., Hönigschnabl S., Stichenwirth M., Pfudl S., Sebald D., Kaff A., et al. Mortality of opiate users in Vienna, Austria. Drug and Alcohol Dependence 2001, 64:251-256.
40. Sanchez-Carbonell X., Seus L. Ten-year survival analysis of a cohort of heroin addicts in Catalonia: The EMETYST project. Addiction 2000, 95:941-948.
41. Segest E., Mygind O., Bay H. The influence of prolonged stable methadone maintenance treatment on mortality and employment: An 8-year follow-up. International Journal of the Addictions 1990, 25(1):53-63.
42. Selwyn P.A., Hartel D., Wasserman W., Drucker E. Impact of the AIDS epidemic on morbidity and mortality among intravenous drug users in a New York City methadone maintenance program. American Journal of Public Health 1989, 79:1358-1362.
43. Stenbacka M., Leifman A., Romelsjö A. Mortality and cause of death among 1705 illicit drug users: A 37year follow up. Drug and Alcohol Review 2010, 29(1):21-27.
44. Tyndall M., Craib K., Currie S., Li K., O'Shaughnessy M.V., Schechter M.T. Impact of HIV infection on mortality in a cohort of injection drug users. Journal of Acquired Immune Deficiency Syndromes 2001, 28:1-9.
45. Vaillant G.E. A 20-year follow-up of New York narcotic addicts. Archives of General Psychiatry 1973, 29:237-241.
46. Walton M.A., Ramanthan C.S., Reischl T.M. Tracking substance abusers in longitudinal research: Understanding follow-up contact difficulty. American Journal of Community Psychology 1998, 26(2):233-253.
47. Ward J., Mattick R.P., Hall W. Methadone maintenance treatment and other opioid replacement therapies 1998, Harwood Academic, Amsterdam.
48. World Medical Association Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. Amended by the 41st World Medical Assembly, Hong Kong, September 1989.
49. Zador D., Sunjic S., Basili H. All-cause mortality rate and risk of dying in methadone maintenance treatment in New South Wales in 1990-1995. National Drug and Alcohol Research Centre, Sydney Monograph Number 35 1998, W. Hall (Ed.).
50. Zanis D.A., Woody G.E. One year mortality rates following methadone treatment discharge. Drug and Alcohol Dependence 1998, 52(3):257-260.